Separate useful neighborhood signals from idle gossip.

Tend plants and quiet outdoor/domestic care.

Prepare basic first-aid support and immediate care.

Regulate tension and calm the nearby social mood.

Mediate disagreement through calm conversation.

Diagnose and repair a computer or small device.

Use basic computer work to prepare messages or records.

Coordinate neighbors and shared town information.

Organize class materials, meetings, and student follow-up.

Follow up on recurring health needs and medication routines.

Offer basic care check-ins for neighbors.

Facebook Research Hand Tracking Challenge Toolkit - evaluation and visualization tools for 3D hand tracking. Supports loading HOT3D data, computing metrics (PA-MPJPE, AUC, etc.), visualizing 3D pose projections, and generating tracking evaluation reports. Essential for benchmarking hand tracking algorithms.

Real-time hand detection in egocentric videos using victordibia/handtracking. Outputs bounding boxes for hands, specifically trained on EgoHands dataset. Supports video input/output with labeled hand boxes. Lightweight and fast for egocentric view applications.

Egocentric Hand-Object Segmentation (EgoHOS) - pixel-level hand and object segmentation in egocentric videos. Outputs fine-grained segmentation masks with hand regions highlighted. Specialized for hand-object interaction scenarios with pixel-accurate masks. Ideal for detailed interaction analysis.

Gather comprehensive biological target intelligence from 9 parallel research paths covering protein info, structure, interactions, pathways, expression, variants, drug interactions, and literature. Features collision-aware searches, evidence grading (T1-T4), explicit Open Targets coverage, and mandatory completeness auditing. Use when users ask about drug targets, proteins, genes, or need target validation, druggability assessment, or comprehensive target profiling.

Analyze drug safety signals from FDA adverse event reports, label warnings, and pharmacogenomic data. Calculates disproportionality measures (PRR, ROR), identifies serious adverse events, assesses pharmacogenomic risk variants. Use when asked about drug safety, adverse events, post-market surveillance, or risk-benefit assessment.

Construct and analyze compound-target-disease networks for drug repurposing, polypharmacology discovery, and systems pharmacology. Builds multi-layer networks from ChEMBL, OpenTargets, STRING, DrugBank, Reactome, FAERS, and 60+ other ToolUniverse tools. Calculates Network Pharmacology Scores (0-100), identifies repurposing candidates, predicts mechanisms, and analyzes polypharmacology. Use when users ask about drug repurposing via network analysis, multi-target drug effects, compound-target-disease networks, systems pharmacology, or polypharmacology.

Comprehensive computational validation of drug targets for early-stage drug discovery. Evaluates targets across 10 dimensions (disambiguation, disease association, druggability, chemical matter, clinical precedent, safety, pathway context, validation evidence, structural insights, validation roadmap) using 60+ ToolUniverse tools. Produces a quantitative Target Validation Score (0-100) with GO/NO-GO recommendation. Use when users ask about target validation, druggability assessment, target prioritization, or "is X a good drug target for Y?"

Identify drug repurposing candidates using ToolUniverse for target-based, compound-based, and disease-driven strategies. Searches existing drugs for new therapeutic indications by analyzing targets, bioactivity, safety profiles, and literature evidence. Use when exploring drug repurposing opportunities, finding new indications for approved drugs, or when users mention drug repositioning, off-label uses, or therapeutic alternatives.

Comprehensive drug-drug interaction (DDI) prediction and risk assessment. Analyzes interaction mechanisms (CYP450, transporters, pharmacodynamic), severity classification, clinical evidence grading, and provides management strategies. Supports single drug pairs, polypharmacy analysis (3+ drugs), and alternative drug recommendations. Use when users ask about drug interactions, medication safety, polypharmacy risks, or need DDI assessment for clinical decision support.